Viewing Study NCT02726568


Ignite Creation Date: 2025-12-24 @ 5:40 PM
Ignite Modification Date: 2026-02-02 @ 8:29 AM
Study NCT ID: NCT02726568
Status: UNKNOWN
Last Update Posted: 2019-02-19
First Post: 2016-03-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases
Sponsor: Betta Pharmaceuticals Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer View
None Brain Metastases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None EGFR-TKI View
None NSCLC View
None Icotinib View
None SRS View
None radiotherapy View